Browse Category

Technology 11 May 2026 - 12 May 2026

Palantir’s NHS Patient Data Fight Tests Its AI Stock Boom

Palantir’s NHS Patient Data Fight Tests Its AI Stock Boom

Britain’s National Health Service is giving outside workers—including Palantir Technologies Inc. contractors—sweeping access to patient-identifiable data as they develop a high-profile health-data platform, the Financial Times said. That move is stirring up an old privacy debate over one of the U.S. software giant’s most sensitive public sector contracts. The permissions extend to the National Data Integration Tenant, or NDIT, a staging layer inside the Federated Data Platform where records remain identifiable before any pseudonymisation, that is, before personal details are hidden.
Applied Digital Just Spun Out ChronoScale: What CHRN Means for APLD Stock Now

Applied Digital Just Spun Out ChronoScale: What CHRN Means for APLD Stock Now

ChronoScale, Applied Digital’s cloud unit, has started trading on Nasdaq under the ticker CHRN. Dallas-based Applied Digital holds about 97% of the new public company after spinning off the business into EKSO Bionics and putting in $15.75 million in cash. Chairman and CEO Wes Cummins described the move as a “deliberate step” to separate long-duration data-center hosting from the cloud compute segment, which he said carries a different risk profile.
Palantir Stock’s Big AI Test: Blowout Growth, But Wall Street Still Wants Proof

Palantir Stock’s Big AI Test: Blowout Growth, But Wall Street Still Wants Proof

Palantir Technologies Inc has raised its 2026 revenue ambitions, but the stock remains below pre-earnings levels—suggesting investors are still debating whether the AI software heavyweight can deliver enough growth. The shares ended Friday at $137.80 on Nasdaq, up 0.55% for the day, yet still down from Monday’s $146.03 close, ahead of the earnings release.
1 63 64 65 66 67 278
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.